Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Singapore trials Smartphone app offering mini check-ups

Published 02/23/2021, 08:16 PM
Updated 02/23/2021, 08:21 PM
© Reuters. Nervotec founder Jonathan Lau shows the comparison in vital signs readings between his company's app and a pulse oxygen monitor, in Singapore

By Joseph Campbell

SINGAPORE (Reuters) - Each morning before work at a Singapore construction site, Gunasekar Udayakumar, 41, gets his vital signs checked, without going to a clinic, or even seeing a nurse.

All he needs is his smartphone, which in just 45 seconds can tell him his heart rate, oxygen levels and even his stress levels.

It can also tell him if he should see a doctor.

    The application, developed by Singapore startup Nervotec, is what construction firm Kajima considers its first line of defence against another outbreak of the coronavirus in Singapore.

The city-state has kept a tight lid on its infections and wants to avoid a repeat of last year, when a series of clusters emerged in migrant worker dormitories.

Kajima staff at various sites have used the application since December as part of a government-initiated programme that provides companies with trial-stage technology to help them adjust to the new pandemic-era norms.

It offers a diagnosis of the user's health condition, relying solely on a smartphone camera that can measure heart rate by picking up changes in the reflectivity of light on the user's skin between heart beats according to blood flow underneath.

Nervotec founder Jonathan Lau said Singapore's government was very interested in the technology.

"We see the most traction coming from healthcare providers, both private and public," he said.

Lau's initial inspiration came from his experiences as an air force pilot, when he underwent constant check-ups.

He eventually founded a company that used wearable devices to monitor pilots. But when the pandemic hit, Lau broadened the focus.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

    The app is still undergoing local review and Chwee Teck Lim, director of the National University of Singapore's Institute of Health Innovation and Technology, said it could have a big impact if approved by regulators

    "What Nervotec is proposing could potentially be a game-changer," Lim said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.